deltatrials
Recruiting OBSERVATIONAL NCT06953076

Ultrasound Transformation of Myomas During Relugolix-Estradiol-Norethisterone Treatment: The MySaturn Study (MySaturn)

MyomaS Aspect Transformation at Ultrasound During Relugolix Estradiol Noretisterone Treatment: MySaturn Study

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions Uterine Bleeding Uterine Hemorrhage Uterine Leiomyomas Uterine Neoplasms
Interventions Relugolix/estradiol/norethisterone acetate
Updated 2 times since 2025 Last updated: Aug 15, 2025 Started: May 2, 2025 Primary completion: May 2, 2026 Completion: May 2, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Uterine Bleeding and Uterine Hemorrhage and is currently actively recruiting participants. Fondazione Policlinico Universitario Agostino Gemelli IRCCS leads this study, which shows 2 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jun 2025 – ~Sep 2025 · 3 months · monthly snapshotNot Yet Recruiting~Sep 2025 – present · 12 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Sep 2025 — Present [monthly]

    Recruiting

    Status: Not Yet Recruiting → Recruiting

  2. Jun 2025 — Sep 2025 [monthly]

    Not Yet Recruiting

    First recorded

May 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Data source: Fondazione Policlinico Universitario Agostino Gemelli IRCCS

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations